Respective effects of phlebotomy losses and erythropoietin treatment on the need for blood transfusion in very premature infants

The benefit to risk ratio of the treatment with erythropoietin (EPO) as a means of limiting the number of transfusions in very preterm infants during hospitalization, seems to be modest since the adoption of restrictive transfusion criteria and of policy limiting phlebotomy losses.